3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
1
Breast Diseases
1
Interventions
Paclitaxel
164
Fulvestrant
158
Trastuzumab
157
pembrolizumab
146
Letrozole
136
Carboplatin
120
pertuzumab
105
Capecitabine
105
Cyclophosphamide
103
Specimen Handling
101
Anastrozole
91
palbociclib
86
abemaciclib
83
Magnetic Resonance Spectroscopy
80
exemestane
77
Docetaxel
76
ribociclib
74
Tamoxifen
74
trastuzumab deruxtecan
67
Radiotherapy
62
Biopsy
58
Surveys and Questionnaires
55
olaparib
53
Gemcitabine
53
130-nm albumin-bound paclitaxel
53
sacituzumab govitecan
51
Blood Specimen Collection
50
Taxes
49
Standard of Care
49
eribulin
48
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Blood Pressure
×
Breast
×
1 year
×
Clear all
NCT05006196
2026-05-20
IMOGEN
Perspectum
Active not recruiting
1,030 enrolled